INCY earnings date and last-quarter result: last quarter miss, P/E 15.86. Updated 2026-07-23.
Incyte (INCY) Research Hub
Incyte (INCY) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 113.31 USD (-2.07%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 15.86, market cap 23.33B. This hub links to the full technical, earnings and options research available for INCY.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 113.31 USD (-2.07%) |
| 52-week range | 98.25 USD – 132.6 USD |
| Trend regime | Range |
| 14-day RSI | 51.2 (Neutral) |
| Trailing P/E | 15.86 |
| Market cap | 23.33B |
| Dividend yield | 0.00% |
Available research for INCY
Covered Call on INCY: how it works, illustrative setup around the real 113.31 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on INCY: how it works, illustrative setup around the real 113.31 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on INCY: how it works, illustrative setup around the real 113.31 USD price, max profit/loss, breakeven and when to use it. Educational.
INCY technical analysis: range, last 113.31 USD, RSI 51.2, 52w range 98.25 USD–132.6 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is INCY in?
Incyte (INCY) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is INCY in an uptrend or downtrend?
As of 2026-10-26, INCY is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is INCY's trailing P/E ratio?
INCY's trailing P/E is 15.86, with a market cap of 23.33B. See the earnings research page for full valuation detail.